title: MD reviewers' role in the new anticancer drug approval process in the newly established Japanese regulatory agency, PMDEC (Pharmaceuticals and Medical Devices Evaluation Center)
authors.forename: Y
authors.initials: Y
authors.lastname: Fujiwara
mesh_terms: D000970:Antineoplastic Agents / Q000592:standards*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004341:Drug Evaluation; D004864:Equipment and Supplies; D006077:Government Agencies; D007564:Japan; D011366:Professional Review Organizations
chemical_list: D000970:Antineoplastic Agents